Table 1 Tenfold Cross-validation p-value mean and standard deviation of CPH models and variable.

From: Identification of CT-based non-invasive radiomic biomarkers for overall survival prediction in oral cavity squamous cell carcinoma

 

1

2

3

4

5

6

7

8

9

10

Mean

SD

A. Overall survival

 GNS

0.010

0.010

0.009

0.012

0.009

0.011

0.012

0.010

0.050

0.017

0.015

0.013

 HLEs

0.013

0.032

0.007

0.023

0.029

0.032

0.011

0.045

0.024

0.011

0.023

0.012

 Stage

0.007

0.004

0.011

0.028

0.008

0.047

0.009

0.034

0.007

0.039

0.019

0.016

 ETOHno

0.065

0.023

0.117

0.094

0.146

0.200

0.036

0.046

0.081

0.031

0.084

0.057

 LRT

2e−06

9e−07

2e−06

3e−05

6e−06

1e−04

1e−06

5e−06

2e−05

1e−05

3e−06

6e−06

 Score

2e−06

3e−06

6e−06

4e−05

2e−05

3e−04

2e−06

6e−06

3e−05

2e−05

6e−06

1e−05

 CItrain

0.729

0.747

0.726

0.717

0.732

0.705

0.739

0.731

0.726

0.722

0.727

0.011

 CItest

0.652

0.537

0.741

0.800

0.658

0.867

0.569

0.650

0.764

0.750

0.699

0.103

B. Absolute survival

 GNS

0.038

0.074

0.067

0.017

0.048

0.027

0.057

0.043

0.036

0.037

0.044

0.018

 HLEs

0.008

0.019

0.033

0.079

0.044

0.012

0.021

0.032

0.014

0.041

0.030

0.021

 Stage

0.034

0.027

0.029

0.056

0.084

0.086

0.051

0.127

0.054

0.065

0.061

0.031

 ETOHno

0.548

0.136

0.294

0.074

0.117

0.110

0.402

0.197

0.267

0.417

0.256

0.158

 LRT

4e−06

7e−06

3e−06

1e−06

3e−05

2e−05

9e−05

4e−05

1e−05

8e−05

3e−05

3e−05

 Score

1e−05

1e−05

1e−05

8e−06

7e−05

4e−05

2e−04

7e−05

4e−05

2e−04

6e−05

6e−05

 CItrain

0.763

0.762

0.752

0.769

0.749

0.747

0.742

0.743

0.745

0.734

0.751

0.011

 CItest

0.673

0.636

0.478

0.467

0.740

0.829

0.850

0.767

0.737

0.882

0.706

0.144